Sequential Treatment with Exemestane and Non-Steroidal Aromatase Inhibitors in Advanced Breast Cancer-Reference-Cited by-同舟云学术

Sequential Treatment with Exemestane and Non-Steroidal Aromatase Inhibitors in Advanced Breast Cancer

Published:2005 Issue:6 Volume:69 Page:471-477
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Bertelli Gianfilippo,Garrone Ornella,Merlano Marco,Occelli Marcella,Bertolotti Laura,Castiglione Federico,Pepi Fiorella,Fusco Ornella,Del Mastro Lucia,Leonard Robert C.F.

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference26 articles.

1. Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial

2. Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study

3. Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group

4. Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring innovative strategies for identifying anti-breast cancer compounds by integrating 2D/3D-QSAR, molecular docking analyses, ADMET predictions, molecular dynamics simulations, and MM-PBSA approaches;Journal of Molecular Structure;2025-01

2. Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin;Breast Cancer Research and Treatment;2021-09-23

3. Changes in serum estrogenic activity during neoadjuvant therapy with letrozole and exemestane;The Journal of Steroid Biochemistry and Molecular Biology;2020-06

4. Actualidades en el manejo sistémico del cáncer de mama;Revista Mexicana de Mastología;2020

5. The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitors;Future Oncology;2019-11